Sintx Stock (NASDAQ:SINT)


RevenueOwnershipFinancialsChart

Previous Close

$3.89

52W Range

$2.01 - $105.80

50D Avg

$3.32

200D Avg

$6.81

Market Cap

$4.91M

Avg Vol (3M)

$1.06M

Beta

1.37

Div Yield

-

SINT Company Profile


Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

43

IPO Date

Feb 13, 2014

Website

SINT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 24Jun 24Mar 24
Grant and Contract$432.00K$481.00K-
Product$367.00K$378.00K$309.00K
Grant And Contract--$378.00K

Fiscal year ends in Dec 23 | Currency in USD

SINT Financial Summary


Dec 23Dec 22Dec 21
Revenue$2.63M$601.00K$606.00K
Operating Income$-13.36M$-11.34M$-10.62M
Net Income$-8.26M$-16.49M$-9.82M
EBITDA$-11.70M$-9.97M$-8.82M
Basic EPS$-2.21$-54.67$-39.78
Diluted EPS$-1.90$-51.96$-39.18

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 17Nov 21, 17 | 2:15 PM
Q3 16Nov 10, 16 | 9:30 PM
Q2 16Aug 11, 16 | 10:50 PM

Peer Comparison


TickerCompany
TIVCTivic Health Systems, Inc.
NXLNexalin Technology, Inc.
NUWENuwellis, Inc.
IRIXIRIDEX Corporation
BBLGBone Biologics Corporation
RSLSReShape Lifesciences Inc.
BJDXBluejay Diagnostics, Inc.
HSDTHelius Medical Technologies, Inc.
NAOVNanoVibronix, Inc.